Charles Schwab Corporation

SCHW
Financial Analysis · Updated May 12, 2026 · Coverage 2026-Q2
Latest Q Revenue
$6.5B
Q1 FY2026 · +15.8% YoY
TTM ROIC
25%
FY2025 · Net Income / Tangible Common Equity (ROTCE) · WACC ~8% · Moat spread +15pp

Financial Snapshot


ticker: SCHW step: 04 generated: 2026-05-12 source: quick-research

The Charles Schwab Corporation (SCHW) — Financial Snapshot

Income Statement Summary

Metric FY2023 FY2024 FY2025 YoY (FY25)
Total Net Revenue $18.8B $19.6B $24.0B+ +22%
Net Interest Revenue $9.1B $9.5B $12B+ +26%
Asset Management & Admin Fees $5.2B $5.7B ~$6.3B +11%
Trading Revenue $3.4B $3.6B ~$4.0B +11%
Total Operating Expenses $13.7B $14.0B ~$13.5B -3.6% (synergy capture)
Net Income $5.1B $5.9B $8.9B +51%
Diluted EPS $2.54 $2.99 ~$4.85 +62%
Net Interest Margin 2.12% 2.12% 2.90% (Q4 25) +78 bps

Q1 2026 Results

Metric Q1 2026
Total Revenue $6.5B
Diluted EPS (record) $1.43
Net Income $2.6B (+30% YoY)
Net Interest Revenue $3.1B (+16% YoY)
Client Assets $11.9T

Client Asset & Account Metrics

Metric Year-end 2024 Q1 2026
Total Client Assets $10.10T $11.9T
Core Net New Assets (TTM) $519B
Active Brokerage Accounts ~36M 45.2M+
RIAs on Platform ~7,000 ~7,000
Client Sweep Cash $425.6B $453.7B

Cash Flow & Capital Allocation (FY2025)

Metric Value
Net Cash from Operations ~$10B
Capital Expenditures ~$0.5B (asset-light)
Free Cash Flow ~$9.5B
Share Repurchases ~$2B
Dividends Paid ~$2.2B
Quarterly Dividend $0.30
Annual Dividend $1.20
Dividend Yield ~1.2%
Tier 1 Leverage Ratio ~10%

TD Ameritrade Integration Synergies

Item Status
Expense Synergy Run-Rate $1.8–2.0B achieved
Revenue Synergy Opportunity $4.3–4.8B (ramping through 2027)
Final Account Conversions Completed May 2024

Key Ratios (approximate)

  • P/E: ~19x (FY26E EPS ~$5.50+) | Price/TBV: ~3x | ROTCE: ~25%+
  • Revenue Growth (FY25): +22% (NIM-driven + synergies)
  • Net Interest Margin: 2.90% (Q4 25, up from 2.12% in 2024)
  • Net Income Growth (FY25): +51%
  • Dividend Yield: ~1.2% | Buyback Yield: ~1.2%
  • Net Income Margin Target: ~39% by FY26 (vs. ~37% FY25)

Growth Profile

FY25 was an exceptional year:

  • Net Income +51% to $8.9B
  • NIM expansion from 2.12% to 2.90% on FHLB + CDs paydown
  • Sweep cash rebuilt to $454B
  • Client assets grew to $11.9T
  • TD Ameritrade integration revenue synergies beginning to layer on top of completed cost synergies

The 2026 setup ("pivot to offense"):

  • Continued NIM expansion as portfolio rotates into higher-yielding assets
  • $4.3–4.8B revenue synergy opportunity from cross-selling Schwab capabilities to legacy TDA clients
  • Net income margin expanding from ~37% (FY25) to ~39% (FY26 target)
  • Q1 2026 record EPS $1.43 + revenue $6.5B confirms operational momentum

Risk: Fed rate cuts compress investment yields on sweep cash (partial offset from lending growth) + ongoing sweep-cash litigation could force industry-wide sweep rate increases.

Forward Estimates

FY2026 Consensus:

  • Revenue: ~$26–28B (+8–17%)
  • EPS: ~$5.50–6.20 (+15–28%)

Bull case: NIM expansion continues to 3.10%; TDA revenue synergies layered in; net income margin reaches 40%; multiple expands to 22x P/E. Bear case: Fed rate cuts deeper than expected; sweep litigation outcome forces rate increases; NIM compresses; multiple compresses to 15x P/E. Consensus targets ~$105–120 vs. trading ~$90–100 (~10–25% implied upside).

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $SCHW.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/SCHW/fundamental$1.00 · Bearer token required
Markdown: /stocks/schw/financials/md · → thesis · → memo